Prescott Group Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Prescott Group Capital Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.37M	Hold	541,845	–	–	0.46%	60
2026 Q1	$3.32M	Hold	541,845	–	–	0.33%	80
2025 Q4	$4.5M	Buy	+541,845	New	+$5.83M	0.42%	66
2025 Q3	–	Sell	-775,568	Closed	-$8.73M	–	242
2025 Q2	$8.73M	Buy	775,568 +409,851	+112%	+$3.18M	1.03%	17
2025 Q1	$2.08M	Buy	365,717 +3,967	+1%	+$40.4K	0.3%	104
2024 Q4	$3.55M	Buy	361,750 +90,000	+33%	+$771K	0.48%	64
2024 Q3	$2.21M	Buy	+271,750	New	+$2.72M	0.32%	100
2023 Q1	–	Sell	-25,825	Closed	-$1.75M	–	175
2022 Q4	$1.75M	Buy	+25,825	New	+$2.38M	0.38%	66

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Prescott Group Capital Management's DNA Position: Q2 2026 in Review

Prescott Group Capital Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 541,845 shares worth $5.37M. The position accounts for 0.46% of the portfolio, ranked #60.

Prescott Group Capital Management first reported a position in DNA in Q4 2022 and has held it in 8 quarters since. The position peaked at $8.73M in Q2 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Prescott Group Capital Management held 541,845 shares of Ginkgo Bioworks worth $5.37M as of Q2 2026.
Prescott Group Capital Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up 0.46% of Prescott Group Capital Management's portfolio in Q2 2026, its #60 holding.
Prescott Group Capital Management first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 8 quarters since.
Prescott Group Capital Management's Ginkgo Bioworks position peaked at $8.73M in Q2 2025.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Prescott Group Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.